Monday, 7 November 2016

SPHPM’s world-first medical trial hits regional Victoria

SPHPM’s pioneering STAREE trial is seeking residents in regional Victoria to take part in this important research. STAtin therapy for Reducing Events in the Elderly (STAREE) looks at whether statins – used to lower cholesterol - can help people aged over 70 live longer, healthier lives.

Trial activity is off and running in Melbourne, Tasmania and Western Australia, with Gippsland added to the mix in October and will be expanding into other regional areas in 2017. The study is aiming for more than 10,000 participants nationwide.

Study organisers are seeking to recruit healthy people aged 70 years and older with no history of heart disease, kidney and liver disease, diabetes or dementia. They are also seeking 1000 general practitioners from across regional Victoria to be involved as co-investigators in the STAREE trial.

Lead trial researcher Professor Sophia Zoungas said the research would look at whether a daily dose of statin therapy could prolong good health and assist in maintaining independence in people aged over 70, including preventing heart attacks, dementia and disability.

“Participants, either taking daily statin or a placebo, will be monitored for an average of five years for heart disease, physical function, changes to cognitive function, diabetes and quality of life metrics such as ability to walk unaided and independence such as cooking for oneself,” Professor Zoungas said.

The trial addresses an unknown medical question about the net effect of preventive medicine for prolonging a healthy life.

If you would like more information, call 1800 770 664 or visit

The trial is being funded by the NHMRC and the Commonwealth, and is not affiliated with any pharmaceutical company.

No comments:

Post a Comment


Related Posts Plugin for WordPress, Blogger...